ANIP
ANIP
NASDAQ · Pharmaceuticals

Ani Pharmaceuticals Inc

$73.92
-0.75 (-1.00%)
As of Mar 23, 10:02 PM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 12 86%
Hold 2 14%
Sell 0 0%
Price Target
Analyst Price Target -50.3% upside
Low Target $28.36
Average Target $36.71
High Target $54.52
Current Price $73.92
Current
$73.92
Target
$36.71
$28.36 $36.71 avg $54.52
Scenario Analysis
Bear Case
$28.36
-61.6%
Low target
Base Case
$36.71
-50.3%
Avg target
Bull Case
$54.52
+-26.2%
High target
Risk/Reward
0.4x
Unfavorable
Price in Context
52-Week High
$99.50
-25.7% from high
52-Week Low
$56.71
+30.3% from low
Target vs 52W High
$36.71
-63.1% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%